Results 231 to 240 of about 24,516 (282)

Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications. [PDF]

PLoS One
Carrillo Infante C, Mujeebuddin A.
europepmc   +1 more source

Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays. [PDF]

Kidney Int Rep
Santarsiero D, Gastoldi S, Guaschino V, Bresin E, Pagani I, Pasini A, Romano E, Benigni A, Remuzzi G, Noris M, Aiello S.   +10 more
europepmc   +1 more source

Extravascular hemolysis in PNH. [PDF]

Blood Adv
Szer J.
europepmc   +1 more source

Therapie von Patienten mit paroxysmaler nächtlicher Hämoglobinurie (PNH) mit Eculizumab

, 2018
Olga Girmann
openalex   +1 more source

Efgartigimod non-responders after the first treatment cycle in generalized myasthenia gravis: a retrospective analysis of predictive factors. [PDF]

Front Neurol
Niu Z, Wang J, Ren J, Liu R, Guo J, Zhang N, Zheng Y, Hao H, Gao F, Jin H.   +9 more
europepmc   +1 more source

Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUS. [PDF]

Nephrol Dial Transplant
Orozco-Leal G, Vale L, Oluboyede Y, Brocklebank V, Bryant A, Chadwick T, Dunn S, Johnson S, Kavanagh D, Kennedy C, Lecouturier J, Weetman C, Wong E, Woodward L, Sheerin NS.   +14 more
europepmc   +1 more source

Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies. [PDF]

Diseases
Apostolidou E, Georgoulis V, Leonardos D, Kapsali E, Hatzimichael E.   +4 more
europepmc   +1 more source

Paroxysmal Nocturnal Hemoglobinuria-Driven Hepatic Vein Thrombosis: A Case of Budd-Chiari Syndrome in Disguise. [PDF]

Cureus
Agrawal S, Prasad S, Nagda J, Parmar V, Reddy A.   +4 more
europepmc   +1 more source